Eli Lilly Balance Sheet Health
Financial Health criteria checks 3/6
Eli Lilly has a total shareholder equity of $14.3B and total debt of $31.2B, which brings its debt-to-equity ratio to 218.1%. Its total assets and total liabilities are $75.6B and $61.3B respectively. Eli Lilly's EBIT is $14.9B making its interest coverage ratio 28.7. It has cash and short-term investments of $3.5B.
Key information
218.1%
Debt to equity ratio
US$31.23b
Debt
| Interest coverage ratio | 28.7x |
| Cash | US$3.52b |
| Equity | US$14.32b |
| Total liabilities | US$61.29b |
| Total assets | US$75.61b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LLYC's short term assets ($31.4B) exceed its short term liabilities ($24.7B).
Long Term Liabilities: LLYC's short term assets ($31.4B) do not cover its long term liabilities ($36.6B).
Debt to Equity History and Analysis
Debt Level: LLYC's net debt to equity ratio (193.5%) is considered high.
Reducing Debt: LLYC's debt to equity ratio has reduced from 442.1% to 218.1% over the past 5 years.
Debt Coverage: LLYC's debt is not well covered by operating cash flow (19.3%).
Interest Coverage: LLYC's interest payments on its debt are well covered by EBIT (28.7x coverage).